SIMILAR PATTERNS OF AMINO ACIDS FOR 4YNM_B_SAMB2304
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1epx | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE (Leishmaniamexicana) |
PF00274(Glycolytic) | 5 | GLY A 136HIS A 88TYR A 147CYH A 155ILE A 115 | None | 1.33A | 4ynmB-1epxA:undetectable | 4ynmB-1epxA:18.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f2j | FRUCTOSE-BISPHOSPHATE ALDOLASE,GLYCOSOMAL (Trypanosomabrucei) |
PF00274(Glycolytic) | 5 | GLY A 136HIS A 88TYR A 147CYH A 155ILE A 115 | None | 1.32A | 4ynmB-1f2jA:undetectable | 4ynmB-1f2jA:21.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hdi | PHOSPHOGLYCERATEKINASE (Sus scrofa) |
PF00162(PGK) | 5 | GLY A 365HIS A 390TYR A 195GLN A 332ILE A 369 | None | 1.40A | 4ynmB-1hdiA:undetectable | 4ynmB-1hdiA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jqp | DIPEPTIDYL PEPTIDASEI (Rattusnorvegicus) |
PF00112(Peptidase_C1)PF08773(CathepsinC_exc) | 5 | ASP A 104HIS A 103TYR A 75HIS A 23ILE A 28 | None | 1.19A | 4ynmB-1jqpA:undetectable | 4ynmB-1jqpA:19.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 339TRP A 340TYR A 381ASN A 409HIS A 410 | None | 0.50A | 4ynmB-1mvhA:15.7 | 4ynmB-1mvhA:30.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.22A | 4ynmB-1pegA:18.2 | 4ynmB-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 160TRP A 161TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.58A | 4ynmB-1pegA:18.2 | 4ynmB-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 160TRP A 161TYR A 204ASN A 241LYS A 306 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 ( 4.0A) | 1.49A | 4ynmB-1pegA:18.2 | 4ynmB-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 7 | TRP A 161ASP A 202TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.63A | 4ynmB-1pegA:18.2 | 4ynmB-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 5 | TRP A 161ASP A 202TYR A 204ASN A 241LYS A 306 | SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 ( 4.0A) | 1.47A | 4ynmB-1pegA:18.2 | 4ynmB-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2afh | NITROGENASEMOLYBDENUM-IRONPROTEIN (Azotobactervinelandii) |
PF00148(Oxidored_nitro)PF11844(DUF3364) | 5 | TRP B 370ASP B 372HIS B 297GLN B 294ILE B 318 | None | 1.15A | 4ynmB-2afhB:undetectable | 4ynmB-2afhB:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ghs | AGR_C_1268P (Agrobacteriumfabrum) |
PF08450(SGL) | 5 | GLY A 219TRP A 236ASN A 233TYR A 244ILE A 211 | None | 1.49A | 4ynmB-2ghsA:undetectable | 4ynmB-2ghsA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TRP A 152HIS A 220TYR A 261CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.35A | 4ynmB-2r3aA:18.9 | 4ynmB-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 151TRP A 152TYR A 193ASN A 219HIS A 220TYR A 261CYH A 287 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 0.53A | 4ynmB-2r3aA:18.9 | 4ynmB-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TYR A 193ASN A 219TYR A 261LYS A 288 | SAM A 304 (-3.5A)SAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)None | 1.17A | 4ynmB-2r3aA:18.9 | 4ynmB-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 153TYR A 193HIS A 220TYR A 261CYH A 287 | NoneSAM A 304 (-4.2A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.41A | 4ynmB-2r3aA:18.9 | 4ynmB-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) | 0.22A | 4ynmB-2w5zA:14.9 | 4ynmB-2w5zA:27.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944 | SAH A4971 ( 3.7A)NoneSAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) | 0.65A | 4ynmB-2w5zA:14.9 | 4ynmB-2w5zA:27.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 136TRP A 137HIS A 210TYR A 248CYH A 275 | SAH A 305 (-3.8A)NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.31A | 4ynmB-3bo5A:19.9 | 4ynmB-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 136TRP A 137TYR A 178ASN A 209HIS A 210TYR A 248CYH A 273 | SAH A 305 (-3.8A)NoneSAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 0.33A | 4ynmB-3bo5A:19.9 | 4ynmB-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 138TYR A 178HIS A 210TYR A 248CYH A 273 | NoneSAH A 305 (-4.0A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.24A | 4ynmB-3bo5A:19.9 | 4ynmB-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16ASN A 205HIS A 206TYR A 252CYH A 274 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.12A | 4ynmB-3n71A:6.1 | 4ynmB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.40A | 4ynmB-3n71A:6.1 | 4ynmB-3n71A:18.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TRP A 103HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.26A | 4ynmB-3ooiA:25.1 | 4ynmB-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 8 | GLY A 102TRP A 103TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219LYS A 220 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A)None | 0.34A | 4ynmB-3ooiA:25.1 | 4ynmB-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 104TYR A 146HIS A 170TYR A 207CYH A 219 | NoneSAM A 237 (-4.1A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) | 1.42A | 4ynmB-3ooiA:25.1 | 4ynmB-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 11 | GLY A2151TRP A2152ASP A2192TYR A2194ASN A2217HIS A2218TYR A2255GLN A2266CYH A2268LYS A2269ILE A2279 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)SAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNoneSAM A 7 (-2.9A) ZN A 1 ( 2.5A)NoneNone | 0.52A | 4ynmB-3opeA:31.2 | 4ynmB-3opeA:98.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | GLY A2151TRP A2152TYR A2194HIS A2218TYR A2255CYH A2270 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.4A)NoneNone ZN A 1 (-2.7A) | 1.36A | 4ynmB-3opeA:31.2 | 4ynmB-3opeA:98.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 7 | HIS A2193TYR A2194ASN A2217HIS A2218TYR A2255CYH A2268ILE A2279 | NoneSAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A)None | 1.33A | 4ynmB-3opeA:31.2 | 4ynmB-3opeA:98.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rc0 | N-LYSINEMETHYLTRANSFERASESETD6 (Homo sapiens) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 74TYR A 223ASN A 251HIS A 252TYR A 285 | SAM A 484 (-3.4A)SAM A 484 (-3.6A)SAM A 484 (-3.1A)NoneSAM A 484 (-4.8A) | 0.88A | 4ynmB-3rc0A:6.6 | 4ynmB-3rc0A:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fc2 | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Mus musculus) |
PF05028(PARG_cat) | 5 | GLY A 723HIS A 798TYR A 785GLN A 781ILE A 754 | NoneSO4 A1007 (-3.8A)NoneNoneNone | 1.35A | 4ynmB-4fc2A:undetectable | 4ynmB-4fc2A:17.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1561TRP A1562ASN A1628HIS A1629CYH A1680 | 0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None ZN A1803 (-2.2A) | 1.38A | 4ynmB-4fmuA:24.1 | 4ynmB-4fmuA:37.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1561TRP A1562TYR A1605ASN A1628HIS A1629GLN A1676CYH A1678 | 0UM A1804 (-3.5A)None0UM A1804 (-4.2A)0UM A1804 (-3.3A)None0UM A1804 (-3.3A) ZN A1803 ( 2.2A) | 0.39A | 4ynmB-4fmuA:24.1 | 4ynmB-4fmuA:37.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.71A | 4ynmB-4mi5A:15.4 | 4ynmB-4mi5A:29.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 7 | GLY A 457TRP A 458TYR A 493ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.56A | 4ynmB-4qeoA:17.0 | 4ynmB-4qeoA:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.55A | 4ynmB-4w2rA:21.2 | 4ynmB-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5408HIS A5539ASN A5474HIS A5475CYH A5525 | SAH A5602 (-3.6A)NoneSAH A5602 (-3.1A)None ZN A5601 ( 2.2A) | 0.96A | 4ynmB-4z4pA:17.4 | 4ynmB-4z4pA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 6 | GLY A5408TYR A5451ASN A5474HIS A5475TYR A5512CYH A5525 | SAH A5602 (-3.6A)SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 0.36A | 4ynmB-4z4pA:17.4 | 4ynmB-4z4pA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 6 | GLY A4782TYR A4825ASN A4848HIS A4849TYR A4886CYH A4899 | SAH A5002 (-3.5A)SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 0.58A | 4ynmB-5f59A:17.3 | 4ynmB-5f59A:24.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 6 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4001 (-3.4A)NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 0.61A | 4ynmB-5f6lA:16.5 | 4ynmB-5f6lA:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | GLY A3842TYR A3883HIS A3907TYR A3944CYH A3957 | NoneNoneSAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 1.50A | 4ynmB-5f6lA:16.5 | 4ynmB-5f6lA:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.46A | 4ynmB-5kjmA:6.7 | 4ynmB-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.72A | 4ynmB-5ls6A:18.1 | 4ynmB-5ls6A:14.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1074TRP A1075TYR A1118ASN A1141HIS A1142TYR A1179CYH A1191 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 0.33A | 4ynmB-5lsuA:25.7 | 4ynmB-5lsuA:36.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 6 | GLY A1074TRP A1075TYR A1118HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.45A | 4ynmB-5lsuA:25.7 | 4ynmB-5lsuA:36.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1076TYR A1118HIS A1142TYR A1179CYH A1191 | SAM A1304 ( 4.6A)SAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 1.44A | 4ynmB-5lsuA:25.7 | 4ynmB-5lsuA:36.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1076TYR A1118HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 4.6A)SAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.05A | 4ynmB-5lsuA:25.7 | 4ynmB-5lsuA:36.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 5 | GLY A 227TYR A 271ASN A 298HIS A 299TYR A 336 | SAM A 401 ( 4.0A)SAM A 401 (-4.1A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A) | 0.29A | 4ynmB-5tegA:15.2 | 4ynmB-5tegA:22.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A1049TRP A1050ASN A1112HIS A1113TYR A1154CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 1.21A | 4ynmB-5tuyA:18.0 | 4ynmB-5tuyA:28.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1049TRP A1050TYR A1085ASN A1112HIS A1113TYR A1154CYH A1168 | SAM A1505 ( 3.9A)NoneSAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 0.32A | 4ynmB-5tuyA:18.0 | 4ynmB-5tuyA:28.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1051TYR A1085HIS A1113TYR A1154CYH A1168 | NoneSAM A1505 (-4.0A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 1.43A | 4ynmB-5tuyA:18.0 | 4ynmB-5tuyA:28.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1137TRP A1138TYR A1173ASN A1200HIS A1201TYR A1242CYH A1256 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) | 0.39A | 4ynmB-5vsdA:18.2 | 4ynmB-5vsdA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A1137TRP A1138TYR A1173HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.38A | 4ynmB-5vsdA:18.2 | 4ynmB-5vsdA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1139TYR A1173HIS A1201TYR A1242CYH A1258 | NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.11A | 4ynmB-5vsdA:18.2 | 4ynmB-5vsdA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.61A | 4ynmB-5wg6A:19.0 | 4ynmB-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.65A | 4ynmB-5xxgA:6.5 | 4ynmB-5xxgA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 7 | GLY A1156TRP A1157TYR A1200ASN A1223HIS A1224TYR A1261CYH A1273 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 0.38A | 4ynmB-6cenA:24.5 | 4ynmB-6cenA:41.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1158TYR A1200HIS A1224TYR A1261CYH A1273 | NoneSAM A1301 (-3.9A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 1.31A | 4ynmB-6cenA:24.5 | 4ynmB-6cenA:41.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1158TYR A1200HIS A1224TYR A1261CYH A1275 | NoneSAM A1301 (-3.9A)NoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.11A | 4ynmB-6cenA:24.5 | 4ynmB-6cenA:41.03 |